1. Home
  2. JAZZ

as 07-19-2024 4:00pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Founded: 2003 Country:
Ireland
Ireland
Employees: N/A City: DUBLIN
Market Cap: 6.9B IPO Year: 2007
Target Price: $185.47 AVG Volume (30 days): 639.6K
Analyst Decision: Buy Number of Analysts: 16
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 4.86 EPS Growth: N/A
52 Week Low/High: $99.06 - $146.70 Next Earning Date: 08-07-2024
Revenue: $3,843,375,000 Revenue Growth: 2.81%
Revenue Growth (this year): 7.77% Revenue Growth (next year): 7.55%

JAZZ Daily Stock ML Predictions

Stock Insider Trading Activity of Jazz Pharmaceuticals plc (Ireland) (JAZZ)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Carr Patricia JAZZ SVP, Chief Accounting Officer Jun 7 '24 Sell $108.83 163 $17,738.48 6,596 SEC Form 4
Patil Neena M JAZZ EVP & Chief Legal Officer May 3 '24 Sell $109.65 5,000 $548,250.00 36,629 SEC Form 4
Carr Patricia JAZZ SVP, Chief Accounting Officer Mar 6 '24 Sell $120.85 1,236 $149,370.60 9,064 SEC Form 4
Carr Patricia JAZZ SVP, Chief Accounting Officer Mar 6 '24 Sell $117.51 700 $82,257.00 8,364 SEC Form 4
Carr Patricia JAZZ SVP, Chief Accounting Officer Mar 6 '24 Sell $116.98 1,768 $206,820.64 6,596 SEC Form 4
Johnson Philip L JAZZ EVP & Chief Financial Officer Mar 1 '24 Buy $119.65 12,000 $1,435,800.00 27,932 SEC Form 4
Smith Mark Douglas JAZZ Director Dec 4 '23 Sell $119.27 417 $49,735.59 6,888 SEC Form 4
Cook Jennifer E. JAZZ Director Dec 4 '23 Sell $119.27 417 $49,735.59 6,888 SEC Form 4

Share on Social Networks: